MDH1 and Candidiasis, Invasive: On evaluating recombinant Mdh1 protein as an antigenic candidate for a vaccine against candidiasis, Shibasaki et al. found that both subcutaneous and intradermal administration of recombinant Mdh1 protein induced significantly higher antibody responses and elicited significant protection against C. albicans mediated systemic infection in mice [288].